T80.8 - Other complications following infusion, transfusion and therapeutic injection
- Applicable to Other complications following infusion, transfusion and therapeutic injection
- The 2025 edition of ICD10-CM T80.8 became effective on October 1, 2024.
- This is the American ICD10-CM version of T80.8 - other international versions of ICD10 T80.8 may differ.
- T80.8 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- T80.8 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
- T80.8 - Other complications following infusion, transfusion and therapeutic injection
- T80.8 - Other complications following infusion, transfusion and therapeutic injection
- T80.81 - Extravasation of vesicant agent
- T80.810 - Extravasation of vesicant antineoplastic chemotherapy
- T80.818 - Extravasation of other vesicant agent
- T80.82 - Complication of immune effector cellular therapy
- T80.89 - Other complications following infusion, transfusion and therapeutic injection
The following codes above T80.8 contain annotation back-references that may be applicable to T80.8:
Chapter: S00-T88 Injury, poisoning and certain other consequences of external causes
Section: T80-T88 Complications of surgical and medical care, not elsewhere classified
Category: T80 Complications following infusion, transfusion and therapeutic injection
Non-Billable/Non-Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com